SCHEMBL11077091

SCHEMBL11077091

CC(=O)Cn1cnc2c1c(=S)n(C)c(=O)n2C

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 7/20 0.58
TRPA1 O75762 1/20 0.57
PDE4A P27815 2/20 0.55
PDE4B Q07343 2/20 0.55
PDE4C Q08493 2/20 0.55
PDE4D Q08499 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
RXFP1 Q9HBX9 3/20 0.53
MAPK1 P28482 2/20 0.53
ADORA2A P29274 1/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
TP53 P04637 1/20 0.51
LMNA P02545 2/20 0.50
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24559305 0.89 ADORA2B (0.74) ADORA2BTRPA1SMN1; SMN2RXFP1MAPK1
SCHEMBL11076150 0.87 RXFP1 (0.62) ADORA2BTRPA1PDE4APDE4BPDE4C
SCHEMBL11531219 0.85 ADORA2B (0.78) ADORA2BTRPA1PDE4APDE4BPDE4C
SCHEMBL24559323 0.85 RXFP1 (0.70) ADORA2BTRPA1PDE4APDE4BPDE4C
SCHEMBL11145310 0.83 PDE4A (0.57) ADORA2BTRPA1PDE4APDE4BPDE4C
SCHEMBL22521980 0.83 ADORA2B (0.52) ADORA2BTRPA1SMN1; SMN2RXFP1MAPK1
SCHEMBL24559396 0.82 ADORA2B (0.73) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL24559298 0.80 ADORA2B (0.61) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL24559134 0.80 RXFP1 (0.56) ADORA2BPDE4ASMN1; SMN2RXFP1MAPK1
SCHEMBL11074992 0.78 PDE4A (0.77) ADORA2BTRPA1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4454138-A TREATMENT OF VASCULAR DISEASES Wuelfing, Johann A. (DE) 1984-06-12 US disclosed
EP-0018136-B1 XANTHINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS BEECHAM - WUELFING GmbH & Co. KG (DE) 1983-11-16 EP disclosed
EP-0018136-A1 Xanthine derivatives, a process for their preparation and their use in pharmaceutical compositions BEECHAM - WUELFING GmbH & Co. KG (DE) 1980-10-29 EP disclosed